IDH1 and central nervous system cancer: We identified 37 differential CSF metabolites between IDH-WT gliomas and controls, 79 differential metabolites between IDH-mutant gliomas and controls, and 63 differential metabolites between IDH-WT and IDH-mutant gliomas (Fig. 4).